Skip to main content

Carla Cisneros Sanchez

Institutions of which they are part

Pediatric Neurology
Vall Hebron Institut de Recerca

Carla Cisneros Sanchez

Institutions of which they are part

Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The donation will enable further characterisation of patients with this rare disease, the identification of new biomarkers and the exploration of innovative therapies.

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Related professionals

Laura Castillo Ribelles

Laura Castillo Ribelles

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Thaïs Murciano Carrillo

Thaïs Murciano Carrillo

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Maria Teresa Fernandez Taranilla

Maria Teresa Fernandez Taranilla

Administration and Management
Cardiovascular Diseases
Read more
José Antonio Navarro Sanchís

José Antonio Navarro Sanchís

Senior researcher
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.